In glioma cell lines, genetic inhibition of ERK5 decreases HGF-induced cell migration and invasiveness in vitro and reduces the expression of the mesenchymal marker N-cadherin and CD44, which are associated with glioma invasiveness. This evidence concerns the gene CD44 and central nervous system cancer.